Last Price$33.90.6%
Market Cap$15.2B
73.9%
Industry median - 84.1%
5Y Historical average - 72.3%
58.8%
Industry median - (115.0%)
5Y Historical average - 63.4%
122.3%
Industry median - (105.2%)
5Y Historical average - 95.8%
N/A
Industry median - 86.4%
5Y Historical average - 198.5%
RPRX Profitability Rating
RPRX Profitability rating
8.4
RPRX Profitability rating performance
RPRX Profitability Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with RPRX Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$15.2B | 8.4 | 73.9% | 57.1% | 81.0% | 37.9% | 122.3% | N/A | |
$402.0B | 8.3 | 84.7% | 44.3% | 51.2% | 34.8% | 24.1% | 69.4% | |
$125.5B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$74.0B | 8.1 | 86.7% | 28.3% | 33.1% | 31.1% | 25.3% | 81.5% | |
$38.1B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$31.3B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$27.1B | 6.7 | 84.3% | (30.8%) | (12.2%) | (15.4%) | 32.4% | (312.1%) | |
$14.8B | 7.0 | 92.3% | 1.5% | 6.2% | 0.8% | 5.5% | 721.1% | |
$14.6B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$14.0B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$1,846.9M | 5.8 | 83.1% | (26.3%) | (22.0%) | (25.9%) | (30.4%) | 117.3% |
FAQ
What is the Royalty Pharma plc (RPRX) gross profit margin?
The Royalty Pharma plc (RPRX) gross profit margin is 73.9%, compared to the industry median of 84.1% and the 5-year historical average of 72.3%.
What is the Royalty Pharma plc (RPRX) operating income margin?
The Royalty Pharma plc (RPRX) operating income margin is 58.8%, compared to the industry median of (115.0%)) and the 5-year historical average of 63.4%.
What is the Royalty Pharma plc (RPRX) Free Cash Flow (FCF) margin?
The Royalty Pharma plc (RPRX) Free Cash Flow margin is 122.3%, compared to the industry median of (105.2%) and the 5-year historical average of 95.8%.
What is the Royalty Pharma plc (RPRX) earnings quality?
The Royalty Pharma plc (RPRX) earnings quality is N/A, compared to the industry median of 86.4% and the 5-year historical average of 198.5%.